Advertisement


Rent Increase Survey

Have you submitted your latest rent increase data to the rent increase survey?

BioTime Inks Deal With Geron for Stem Cell Assets

BioTime is moving forward on it’s $53 million deal to purchase stem cell research and development assets from Geron Corporation. (Google Street View)

BioTime, Inc., an Alameda-based biotechnology company, announced today that it has signed a deal with Geron Corporation to acquire intellectual property and other assets related to human embryonic stem cell programs […]

Continue reading…

BioTime Moves Forward on Stem Cell Asset Acquisition

BioTime is moving forward on it’s $53 million deal to purchase stem cell research and development assets from Geron Corporation. (Google Street View)

Alameda biotech firm BioTime announced late yesterday that it is making progress on its efforts to acquire stem cell research and development assets from Geron Corporation of Menlo Park.

[…]

Continue reading…

BioTime Tries to Woo Geron Shareholders

BioTime of Alameda has made a bid for stem cell research assets owned by Geron Corporation.

Alameda’s BioTime has issued an open letter to shareholders of Geron Corporation, encouraging them to support a $53 million deal that would see a BioTime subsidiary acquire stem cell research and development assets from Geron.

[…]

Continue reading…

  • Economic Development Task Force to Meet https://t.co/QK8pKabUgN ,
  • Overnight Shooting Causes Closure of Southbound I-880 https://t.co/lb7Gm3cnO4 ,
  • Economic Development Task Force to Meet https://t.co/JH92PQQ9z9 ,
  • https://t.co/tEsxUviNvB ,
  • College of Alameda Awarded Makerspace Grant https://t.co/FtBwsi7Qzu ,

Directories